Zobrazeno 1 - 10
of 99
pro vyhledávání: '"Donald M, Bushnell"'
Autor:
Enrique Alvarez, Joanne Fielding, John Parratt, Ivan J Clement, Dorsa Khazaei, Cecilia Jimenez-Moreno, Donald M Bushnell, Diogo Santos-Pata
Publikováno v:
BMJ Neurology Open, Vol 6, Iss Suppl 1 (2024)
Externí odkaz:
https://doaj.org/article/5bf861b66d414b3b9a2d93831765863b
Autor:
Meryl Brod, Donald M. Bushnell, Jesper Skov Neergaard, Laura Tesler Waldman, Anne Kirstine Busk
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 7, Iss 1, Pp 1-23 (2023)
Abstract Background To capture the broad range of treatment burden issues experienced by adolescent and adult people with hemophilia (PWH), the Hemophilia Treatment Experience Measure (Hemo-TEM) was developed. We describe the development of this new
Externí odkaz:
https://doaj.org/article/2ff47f0b4b2047fe8f4f7be1ab2f040e
Autor:
Jeffrey Swigris, Katelyn Cutts, Natalia Male, Michael Baldwin, Klaus B. Rohr, Donald M. Bushnell
Publikováno v:
ERJ Open Research, Vol 7, Iss 2 (2021)
The Living with Idiopathic Pulmonary Fibrosis (L-IPF) questionnaire was developed with substantial input from patients with idiopathic pulmonary fibrosis (IPF) to assess symptoms and health-related quality of life (HRQoL). Because IPF is the prototyp
Externí odkaz:
https://doaj.org/article/2628793232a245ae81c74f7c7f901f90
Autor:
Donald M. Bushnell, MA, Thomas M. Atkinson, PhD, Kelly P. McCarrier, PhD, Astra M. Liepa, PharmD, Kendra P. DeBusk, PhD, Stephen Joel Coons, PhD
Publikováno v:
Current Therapeutic Research, Vol 95, Iss , Pp 100642- (2021)
ABSTRACT: Background: The Non–Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ) was developed to incorporate the patient's perspective into evaluation of clinical benefit in advanced non–small cell lung cancer trials and meet re
Externí odkaz:
https://doaj.org/article/8a6efa162794453a945beaf5008c4499
Autor:
Diane L Kamen, Julie A Birt, Monica A Hadi, Elizabeth Gibbons, Donald M Bushnell, Ren Yu, Laure A Delbecque, Kirstin Griffing, Anca Askanase
Publikováno v:
Lupus. 32:342-351
Background Many people with systemic lupus erythematosus (SLE) experience joint pain, swelling, and stiffness. These joint symptoms are associated with problems in physical functioning and work disability. We used survey data from adults with SLE to
Autor:
Meryl Brod, Michael Højby Rasmussen, Suzanne Alolga, Jane F. Beck, Donald M. Bushnell, Kai Wai Lee, Aristides Maniatis
Publikováno v:
PharmacoEconomics - Open. 7:121-138
Autor:
Thorin L. Geister, Donald M. Bushnell, Jie Yang, Yuqiong Zhang, Mona L. Martin, Alev Heilbronn, Zhenhuan Liu
Publikováno v:
Health and Quality of Life Outcomes, Vol 15, Iss 1, Pp 1-13 (2017)
Abstract Background The Questionnaire on Pain caused by Spasticity (QPS) is a modular patient- and observer-reported outcome measure of spasticity-related pain (SRP) in children with cerebral palsy (CP). Originally developed for an English-speaking p
Externí odkaz:
https://doaj.org/article/db735d8572374c6d9460c289270cf29a
Autor:
Sonya, Eremenco, Wen-Hung, Chen, Steven I, Blum, Elizabeth Nicole, Bush, Donald M, Bushnell, Kendra, DeBusk, Adam, Gater, Linda, Nelsen, Stephen Joel, Coons
Publikováno v:
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 31(12)
Score reproducibility is an important measurement property of fit-for-purpose patient-reported outcome (PRO) measures. It is commonly assessed via test-retest reliability, and best evaluated with a stable participant sample, which can be challenging
Autor:
Natalia Male, Michael Baldwin, Katelyn Cutts, Jeffrey J. Swigris, Klaus B Rohr, Donald M. Bushnell
Publikováno v:
ERJ Open Research, Vol 7, Iss 2 (2021)
ERJ Open Res
ERJ Open Res
The Living with Idiopathic Pulmonary Fibrosis (L-IPF) questionnaire was developed with substantial input from patients with idiopathic pulmonary fibrosis (IPF) to assess symptoms and health-related quality of life (HRQoL). Because IPF is the prototyp
Autor:
Donald M. Bushnell, Knud Vad, Michael Højby Rasmussen, Meryl Brod, Jacques Bedoin, Suzanne Alolga, Aristides Maniatis
Publikováno v:
PharmacoEconomics Open
Objective The aim of this study was to perform psychometric testing of the Growth Hormone Deficiency-Child Impact Measure (GHD-CIM): a patient-reported outcome (PRO) for children with GHD aged 9 to 0.70), as was test–retest reliability for the SWB,